P-490 A chinese, multicenter, phase II trial of gefitinib (IRESSA) inpatients with non-small cell lung cancer who had failed previous chemotherapyZ GUAN, L ZHANG,L LI, G JIANG,X LIU, D CHU,W LILung Cancer（2005）引用 0|浏览4暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
